Stereotactic radiosurgery alone for brain metastases

The Lancet Oncology

Volumn 16, Issue 3, 2015, Pages 249-250

  Sahgal, Arjun ^a   Larson, David ^b   Knisely, Jonathan ^c  

^a DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c DONALD AND BARBARA ZUCKER SCHOOL OF MEDICINE AT HOFSTRA NORTHWELL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN DYSFUNCTION; BRAIN METASTASIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; COGNITION; HIGH RISK PATIENT; HUMAN; KARNOFSKY PERFORMANCE STATUS; NEUROPROTECTION; NON SMALL CELL LUNG CANCER; NOTE; PRIORITY JOURNAL; QUALITY OF LIFE; STEREOTACTIC RADIOSURGERY; WHOLE BRAIN RADIATION THERAPY; ADJUVANT THERAPY; BRAIN NEOPLASMS; MORTALITY; PATIENT SELECTION; RADIOSURGERY; RISK FACTOR; SECONDARY; SKULL IRRADIATION; TREATMENT OUTCOME;

BRAIN NEOPLASMS; CRANIAL IRRADIATION; HUMANS; PATIENT SELECTION; RADIOSURGERY; RADIOTHERAPY, ADJUVANT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84924859396     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(14)71106-4     Document Type: Note

References (11)

1. Tsao M, Xu W, Sahgal A A meta-analysis evaluating stereotactic radiosurgery, whole-brain radiotherapy, or both for patients presenting with a limited number of brain metastases. Cancer 2012, 118:2486-2493.
2. Andrews DW, Scott CB, Sperduto PW, et al. Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 2004, 363:1665-1672.
3. Patchell RA, Tibbs PA, Walsh JW, et al. A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 1990, 322:494-500.
4. Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 2009, 10:1037-1044.
5. Kocher M, Soffietti R, Abacioglu U, et al. Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study. J Clin Oncol 2010, 29:134-141.
6. Sun A, Bae K, Gore EM, Movsas B, et al. Phase III trial of prophylactic cranial irradiation compared with observation in patients with locally advanced non-small-cell lung cancer: neurocognitive and quality-of-life analysis. J Clin Oncol 2011, 29:279-286.
7. Brown PD, Pugh S, Laack NN, et al. Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial. Neuro Oncol 2013, 15:1429-1437.
8. Gondi V, Pugh SL, Tome W, Caine C, Corn B, Kanner A, et al. Preservation of memory with conformal avoidance of the hippocampal neural stem cell compartment during whole-brain radiotherapy for brain metastases (RTOG 0933): a phase 2 multi-institutional trial. J Clin Oncol 2014, published online Oct 27. 10.1200/JCO.2014.57.2909.
9. Sahgal A, Aoyama H, Kocher M, et al. Phase 3 trials of stereotactic radiosurgery with or without whole-brain radiation therapy for 1 to 4 brain metastases: individual patient data meta-analysis. Int J Radiat Oncol Biol Phys 2015, (in press).
10. ASTRO releases second list of five radiation oncology treatments to question, as part of national Choosing Wisely campaign Choose Wisely, (accessed Dec 2, 2014). http://www.choosingwisely.org/astro-releases-second-list/.
11. Yamamoto M, Serizawa T, Shuto T, et al. Stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901): a multi-institutional prospective observational study. Lancet Oncol 2014, 15:387-395.